Correlation Between Mineralys Therapeutics, and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Foghorn Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Foghorn Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and Foghorn Therapeutics
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Foghorn is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Foghorn Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 7.65 times less return on investment than Foghorn Therapeutics. But when comparing it to its historical volatility, Mineralys Therapeutics, Common is 1.61 times less risky than Foghorn Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Foghorn Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 650.00 in Foghorn Therapeutics on August 28, 2024 and sell it today you would earn a total of 140.00 from holding Foghorn Therapeutics or generate 21.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 91.31% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Foghorn Therapeutics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Foghorn Therapeutics |
Mineralys Therapeutics, and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Foghorn Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
| Foghorn Therapeutics vs. Eliem Therapeutics | Foghorn Therapeutics vs. HCW Biologics | Foghorn Therapeutics vs. Scpharmaceuticals | Foghorn Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |